-
- Yong Min Oh VP,
Webinar Presentation invited by Merck
- Yong Min Oh VP,
-
- EAACI Congress 2019
- The Novel Long-Acting IgE Trap-Fc Fusion Protein GI301 Elicits Therapeutic Synergy In Combination with Probiotics For The Treatment Of Food Allergy
-
- Microbiome movement drug development summit 2019
- GI-301, a novel long-acting IgE Trap-Fc fusion protein that elicits therapeutic synergy in combination with a microbiome agent for the treatment of food allergy